Raleigh, NC – Noverant is pleased to announce that it has selected Sequence, Inc. as a major channel partner. Under the non-exclusive, long term agreement, Sequence will lead the sales, marketing and account management efforts in a number of markets, initially focused on pharmaceutical, biotech, and medical device industries. Commenting on the major alliance, Dr. Frank Gozzo, president and CEO of Noverant stated, “Noverant has enjoyed 6 consecutive years of strategic growth and is now…

RALEIGH, NC – Noverant is pleased to announce that the latest release of their learning management system, Noverant Online Enterprise 3, has been deployed worldwide and client feedback regarding the new device-independent design is outstanding. The latest upgrade, which includes many new features including industry-first performance and financial analytics, is now available on any computing device including standard computers, laptops, tablets, iPads and smartphones. Commenting on the major release, Jim Tringas, VP of Global Marketing stated: “Noverant serves clients on six…

In a recent article posted on Pharmaceutical Compliance Monitor, Dr. Frank Gozzo, president and CEO of Noverant, discusses the FDA’s move towards a more transparent and collaborative approval process. He explains why this change is being made and how it requires companies within the pharmaceutical industry to maintain robust compliance management systems. To learn more about why strong compliance engines are important and the impact that they can have on developing a cooperative relationship between manufacturers and…